COGT
Price
$7.24
Change
-$0.38 (-4.99%)
Updated
Jun 18 closing price
Capitalization
824.32M
54 days until earnings call
IDYA
Price
$21.86
Change
-$0.06 (-0.27%)
Updated
Jun 18 closing price
Capitalization
1.91B
54 days until earnings call
Interact to see
Advertisement

COGT vs IDYA

Header iconCOGT vs IDYA Comparison
Open Charts COGT vs IDYABanner chart's image
Cogent Biosciences
Price$7.24
Change-$0.38 (-4.99%)
Volume$3.1M
Capitalization824.32M
IDEAYA Biosciences
Price$21.86
Change-$0.06 (-0.27%)
Volume$1.05M
Capitalization1.91B
COGT vs IDYA Comparison Chart in %
Loading...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COGT vs. IDYA commentary
Jun 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COGT is a StrongBuy and IDYA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 20, 2025
Stock price -- (COGT: $7.24 vs. IDYA: $21.86)
Brand notoriety: COGT and IDYA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COGT: 201% vs. IDYA: 80%
Market capitalization -- COGT: $824.32M vs. IDYA: $1.91B
COGT [@Biotechnology] is valued at $824.32M. IDYA’s [@Biotechnology] market capitalization is $1.91B. The market cap for tickers in the [@Biotechnology] industry ranges from $335.78B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COGT’s FA Score shows that 0 FA rating(s) are green whileIDYA’s FA Score has 0 green FA rating(s).

  • COGT’s FA Score: 0 green, 5 red.
  • IDYA’s FA Score: 0 green, 5 red.
According to our system of comparison, IDYA is a better buy in the long-term than COGT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COGT’s TA Score shows that 5 TA indicator(s) are bullish while IDYA’s TA Score has 5 bullish TA indicator(s).

  • COGT’s TA Score: 5 bullish, 4 bearish.
  • IDYA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both COGT and IDYA are a good buy in the short-term.

Price Growth

COGT (@Biotechnology) experienced а -0.28% price change this week, while IDYA (@Biotechnology) price change was -0.27% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.32%. For the same industry, the average monthly price growth was +13.75%, and the average quarterly price growth was +8.90%.

Reported Earning Dates

COGT is expected to report earnings on Aug 12, 2025.

IDYA is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+7.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDYA($1.92B) has a higher market cap than COGT($824M). COGT YTD gains are higher at: -7.179 vs. IDYA (-14.942). COGT has higher annual earnings (EBITDA): -284.04M vs. IDYA (-356.46M). IDYA has more cash in the bank: 693M vs. COGT (246M). COGT has less debt than IDYA: COGT (17.1M) vs IDYA (26M). IDYA has higher revenues than COGT: IDYA (7M) vs COGT (0).
COGTIDYACOGT / IDYA
Capitalization824M1.92B43%
EBITDA-284.04M-356.46M80%
Gain YTD-7.179-14.94248%
P/E RatioN/AN/A-
Revenue07M-
Total Cash246M693M35%
Total Debt17.1M26M66%
FUNDAMENTALS RATINGS
COGT vs IDYA: Fundamental Ratings
COGT
IDYA
OUTLOOK RATING
1..100
1775
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
62
Fair valued
PROFIT vs RISK RATING
1..100
6864
SMR RATING
1..100
9994
PRICE GROWTH RATING
1..100
4047
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IDYA's Valuation (62) in the null industry is in the same range as COGT (82) in the Miscellaneous industry. This means that IDYA’s stock grew similarly to COGT’s over the last 12 months.

IDYA's Profit vs Risk Rating (64) in the null industry is in the same range as COGT (68) in the Miscellaneous industry. This means that IDYA’s stock grew similarly to COGT’s over the last 12 months.

IDYA's SMR Rating (94) in the null industry is in the same range as COGT (99) in the Miscellaneous industry. This means that IDYA’s stock grew similarly to COGT’s over the last 12 months.

COGT's Price Growth Rating (40) in the Miscellaneous industry is in the same range as IDYA (47) in the null industry. This means that COGT’s stock grew similarly to IDYA’s over the last 12 months.

COGT's P/E Growth Rating (100) in the Miscellaneous industry is in the same range as IDYA (100) in the null industry. This means that COGT’s stock grew similarly to IDYA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COGTIDYA
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
63%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
75%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 17 days ago
76%
Declines
ODDS (%)
Bearish Trend 7 days ago
83%
Bearish Trend 2 days ago
77%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
75%
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DCSCX62.270.07
+0.11%
Davis Balanced Fund C
COFRX37.32N/A
N/A
Columbia Contrarian Core Inst2
VICVX24.19N/A
N/A
USA Mutuals Vice Institutional
JIJRX14.65N/A
N/A
JHancock International Dynamic Gr R6
MIOIX32.23N/A
N/A
Morgan Stanley Inst International Opp I

COGT and

Correlation & Price change

A.I.dvisor indicates that over the last year, COGT has been loosely correlated with SPHDF. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if COGT jumps, then SPHDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COGT
1D Price
Change %
COGT100%
-4.99%
SPHDF - COGT
63%
Loosely correlated
N/A
IDYA - COGT
55%
Loosely correlated
-0.27%
XNCR - COGT
55%
Loosely correlated
+0.60%
CGON - COGT
53%
Loosely correlated
+0.15%
ATXS - COGT
52%
Loosely correlated
+3.33%
More

IDYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDYA has been loosely correlated with IMNM. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if IDYA jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDYA
1D Price
Change %
IDYA100%
-0.27%
IMNM - IDYA
60%
Loosely correlated
-1.34%
CGON - IDYA
60%
Loosely correlated
+0.15%
CRNX - IDYA
56%
Loosely correlated
-1.13%
XENE - IDYA
56%
Loosely correlated
+0.63%
COGT - IDYA
55%
Loosely correlated
-4.99%
More